<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>BuyingValue.com &#187; Intangibles</title>
	<atom:link href="http://buyingvalue.com/tag/intangibles/feed/" rel="self" type="application/rss+xml" />
	<link>http://buyingvalue.com</link>
	<description>Price is What you Pay Value is What you Get</description>
	<lastBuildDate>Fri, 08 Apr 2011 23:09:02 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>Abbott Labratories Review</title>
		<link>http://buyingvalue.com/2009/10/abbott-labratories-review/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=abbott-labratories-review</link>
		<comments>http://buyingvalue.com/2009/10/abbott-labratories-review/#comments</comments>
		<pubDate>Mon, 12 Oct 2009 20:34:11 +0000</pubDate>
		<dc:creator>value investor</dc:creator>
				<category><![CDATA[Stock Analysis]]></category>
		<category><![CDATA[Abbott Laboratories]]></category>
		<category><![CDATA[Abbott Labs]]></category>
		<category><![CDATA[Dividend]]></category>
		<category><![CDATA[Health Care Products]]></category>
		<category><![CDATA[Intangibles]]></category>
		<category><![CDATA[Inventory Management]]></category>
		<category><![CDATA[Pharmaceutical Products]]></category>
		<category><![CDATA[Proven Track Record]]></category>

		<guid isPermaLink="false">http://buyingvalue.com/?p=1389</guid>
		<description><![CDATA[I make it a fairly regular habit of having a look at companies that care about their dividend. The dividend aristocrat list has always been a good starting place for me as these stocks have a proven track record of tailoring themselves to the dividend investor. Abbott Labs appears in the 2009 version of this [...]]]></description>
		<wfw:commentRss>http://buyingvalue.com/2009/10/abbott-labratories-review/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Red Flags: Intangibles</title>
		<link>http://buyingvalue.com/2009/10/red-flags-intangibles/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=red-flags-intangibles</link>
		<comments>http://buyingvalue.com/2009/10/red-flags-intangibles/#comments</comments>
		<pubDate>Sat, 03 Oct 2009 22:01:05 +0000</pubDate>
		<dc:creator>value investor</dc:creator>
				<category><![CDATA[Fundamentals]]></category>
		<category><![CDATA[Balance Sheet]]></category>
		<category><![CDATA[First Encounter]]></category>
		<category><![CDATA[Inclination]]></category>
		<category><![CDATA[Intangible Assets]]></category>
		<category><![CDATA[Intangibles]]></category>
		<category><![CDATA[Patents Trademarks]]></category>
		<category><![CDATA[Red Flag]]></category>
		<category><![CDATA[Value Investor]]></category>

		<guid isPermaLink="false">http://buyingvalue.com/?p=1367</guid>
		<description><![CDATA[I very much dislike intangible assets, the growth or continued presence of them on a balance sheet always throws up a red flag for me. Maybe it is due to my value investor perspective but giving financial credence to a resource that I can&#8217;t see, can&#8217;t touch and can&#8217;t prove generated a cent of revenue [...]]]></description>
		<wfw:commentRss>http://buyingvalue.com/2009/10/red-flags-intangibles/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Minified using disk: basic
Page Caching using disk: enhanced
Object Caching 638/707 objects using disk: basic

Served from: buyingvalue.com @ 2012-05-23 05:45:29 -->
